New treatment reduces injections for patients with debilitating eye disease
The United Kingdom has approved the use of a new drug, faricimab, which considerably reduces the frequency of treatments. From now on, patients will only require three injections per year, compared to one per month with current treatments. This medical progress could benefit more than 11,000 people in the United Kingdom, marking a major turning … Read more